Thomas Needham
Director at Broadview Ventures Inc
Greater Boston
Overview
Work Experience
Director
2018 - Current
Healthcare venture capital
Broadview Ventures invests in businesses that focus on the development of technology solutions in cardiovascular and neurovascular diseases.
Chief Business Officer
2017 - 2018
Head of Corporate Business Development
Merrimack is a biopharmaceutical company that designs and develops medicines to treat cancer.
Raised $432,013,000.00 from Hercules Capital.
Senior Vice President, Business Development
2016 - 2017
Head of Corporate Business Development
C4 Therapeutics develops novel early stage therapies that eliminate disease-causing proteins.
Raised $298,800,000.00 from Betta Pharmaceuticals and Taiwania Capital Management Corporation.
Managing Director
2007 - 2016
Healthcare private equity & venture capital
Principal
2002 - 2007
Healthcare private equity & venture capital
Sunley House Capital Management is an investment manager focused primarily on publicly traded securities.
Vice President, Business Development
2000 - 2002
Vice President, Business Development
1994 - 2000